XNYS · Healthcare · Diagnostics & Research
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Q1 2026 | 2.36 | 2.50 | +5.93% | $2.90B | ✅ Beat | +0.33% | -4.87% | -5.47% |
| 2026-02-10 | Q4 2025 | 2.35 | 2.42 | +2.98% | $2.81B | ✅ Beat | +1.10% | +0.07% | -2.18% |
| 2025-10-21 |
| Q3 2025 |
| 2.51 |
| 2.60 |
| +3.59% |
| $2.82B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-04-22 | Q1 2025 | 2.15 | 2.21 | +2.79% | $2.65B | ✅ Beat | +0.42% | +3.27% | -1.86% |
| 2025-01-30 | Q4 2024 | 2.18 | 2.23 | +2.29% | $2.62B | ✅ Beat | -0.65% | -0.93% | +7.78% |
| 2024-10-22 | Q3 2024 | 2.26 | 2.30 | +1.77% | $2.49B | ✅ Beat | -0.22% | -0.96% | +4.08% |
| 2024-07-23 | Q2 2024 | 2.34 | 2.35 | +0.43% | $2.40B | ✅ Beat | +2.09% | +1.37% | +8.43% |
| 2024-04-23 | Q1 2024 | 1.85 | 2.04 | +10.27% | $2.37B | ✅ Beat | +0.62% | +1.08% | +2.44% |
Showing last 8 quarters.